NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 30.77 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $22.826 million which beat the analyst consensus estimate of $22.654 million by 0.76 percent. This is a 17.05 percent increase over sales of $19.501 million the same period last year.